Medanta

SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference

Retrieved on: 
Monday, January 22, 2024
Aster, Artificial intelligence, General surgery, Urology, Apollo Hospitals, The Honourable, RGCI, Hysterectomy, Cholecystectomy, Medanta, OTC, Conference, Hospital, Cystectomy, Mantra, Incisional hernia, Medical device

FORT LAUDERDALE, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, is proud to have presented the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference (SMRSC), that was held at The Leela Ambience Hotel in Gurugram, Haryana, India on January 19 and 20, 2024. The meeting was highly attended with more than 600 visitors over the course of two days.

Key Points: 
  • 13 Live, broadcasted surgeries were performed by distinguished multi-specialty surgeons, using the SSi Mantra Surgical Robotic System
    Distinguished guests included the Honorable Governor of Haryana, Mr. Bandaru Dattatreya
    FORT LAUDERDALE, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, is proud to have presented the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference (SMRSC), that was held at The Leela Ambience Hotel in Gurugram, Haryana, India on January 19 and 20, 2024.
  • SMRSC 2024 was a transformative event that brought together global medical experts, technological innovators, and visionaries to explore the future of robotic surgery, with a specific focus on SS Innovations’ flagship surgical robotic system, the SSi Mantra.
  • SMRSC 2024 was a productive and educational event that showcased the SSi Mantra, SS Innovations’ technologically advanced, affordable, and accessible surgical robotic system, and SSi Maya, our groundbreaking virtual and mixed reality development division that we anticipate will allow us to launch robotic programs using tele-proctoring and tele-surgery.
  • The conference endeavors to set the stage for the future of healthcare with the SSi Mantra Surgical Robotic System.

SS Innovations Achieves Significant Milestones in 2023

Retrieved on: 
Monday, January 8, 2024
Mantra, FDA, Lung, MISTIC, OTC, Surgery, General surgery, Conference, Pneumonectomy, Johns Hopkins Hospital, Johns Hopkins University, Republic, Johns Hopkins, Aster, Trauma, Medanta, Partnership, MIMA, Sale, CIS, Surgeon, Hospital, MD, CE, Head, Pericardium, Growth, CDSCO, SSI

FORT LAUDERDALE, Fla., Jan. 08, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today provided shareholders and the investment community with a review of the significant milestones the Company achieved in 2023.

Key Points: 
  • FORT LAUDERDALE, Fla., Jan. 08, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today provided shareholders and the investment community with a review of the significant milestones the Company achieved in 2023.
  • Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, and a pioneer in robotic cardiothoracic surgery, stated, “SS Innovations built a strong foundation in 2023 and has laid the groundwork to achieve significant milestones in the years ahead.
  • Also in December 2023, SS Innovations received the Best Company in Robotic Surgery award by the Healthcare Planning and Infrastructure Expo Conference and Awards in New Delhi, India.
  • In November 2023, the Company marked another significant milestone by announcing the successful completion of 500 robotic surgeries across India using SSi Mantra Surgical Robotic System.

The Global Medical Tourism Market to Surge at a CAGR of 11.04% by 2027 | DelveInsight

Retrieved on: 
Tuesday, August 2, 2022
Penang Adventist Hospital, Medanta, Treatment, Insurance, Medicine, Metro AG, Industry, Tourism, Government, Ministry of Tourism (India), Cardiovascular disease, Partnership, Medical tourism, Health, Dental care, Travel, Asian Institute of Medical Sciences, USD, COVID-19, Cancer, CAGR, Adoption, GOI, Ministry, LAS, Howard University Hospital, Patient, Ministry of AYUSH, Samitivej, Principal Scientific Adviser to the Government of India, Fortis Healthcare, Prevalence, Health insurance, Hospital, Asia-Pacific, Hospital

LAS VEGAS, Aug. 2, 2022 /PRNewswire/ -- DelveInsight's Medical Tourism Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies' market shares, challenges, medical tourism market drivers, barriers, and trends, and key medical tourism companies in the market.

Key Points: 
  • LAS VEGAS, Aug. 2, 2022 /PRNewswire/ -- DelveInsight's Medical Tourism Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies' market shares, challenges, medical tourism market drivers, barriers, and trends, and key medical tourism companies in the market.
  • As per DelveInsight analysis, Asia Pacific is anticipated to dominate the global medical tourism market during the forecast period.
  • Additionally, government activities in the region to encourage medical tourism services could be a driving force for the medical tourism market.
  • To know more about why the Asia Pacific is leading the market growth in the medical tourism market, get a snapshot of the report Medical Tourism Market .